Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300.
Saved in:
| Title: | Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300. |
|---|---|
| Authors: | Hettler F; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Schreck C; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Marquez SR; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Engleitner T; Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, Munich., Vilne B; Bioinformatics Research Unit, Riga Stradins University, Riga, Latvia; netOmics, Riga., Landspersky T; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Weidner H; Bone Lab Dresden, Department of Medicine III and Center for Healthy Aging, Technische Universitaet Dresden, Dresden., Hausinger R; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich., Mishra R; Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; School of Medicine, Institute of Clinical Chemistry and Pathobiochemistry, Technical University of Munich, Munich., Oellinger R; Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, Munich., Rauner M; Bone Lab Dresden, Department of Medicine III and Center for Healthy Aging, Technische Universitaet Dresden, Dresden., Naumann R; Max Planck Institute of Molecular Cell Biology and Genetics, Transgenic Core Facility., Peschel C; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg., Bassermann F; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg., Rad R; Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg., Istvanffy R; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich, Germany; Current address: Technical University of Munich, School of Medicine, Surgery Department, 81675 Munich., Oostendorp RAJ; Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich. robert.oostendorp@tum.de. |
| Source: | Haematologica [Haematologica] 2023 Feb 01; Vol. 108 (2), pp. 490-501. Date of Electronic Publication: 2023 Feb 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
